Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Barbara F Williams"'
Autor:
Quashana D Brown, Natasha P. Clayton, Heather Jensen, Pamela Ovwigho, Darlene Dixon, Tonia Hermon, Barbara F Williams, Sreenivasa Ramaiahgari, Alanna Burwell
Publikováno v:
Toxicologic Pathology. 46:653-659
The use of three-dimensional (3-D) in vitro culture systems (spheroids, organoids) in biomolecular and drug discovery research has become increasingly popular. The popularity is due, in part, to a diminished reliance on animal bioassays and a desire
Autor:
Ralph A.H. Stewart, Philip A. Aylward, Carmen G. De Pasquale, Barbara F. Williams, Rachel O'Connell, John J. Edmond, Harvey D. White, R. John Simes, John K. French
Publikováno v:
The American Journal of Cardiology. 97:947-951
Multiple unstable plaques have been demonstrated by various imaging techniques in culprit and nonculprit arteries in patients with acute coronary syndromes, but the frequency with which clinical manifestations of multiple unstable plaques occur is un
Publikováno v:
The Lancet. 361:918-922
Summary Background Anxiety, fear, pain, and treatment with morphine might compromise the ability of patients to comprehend information about, and give informed consent for, participation in clinical trials. We aimed to assess whether patients with ac
Autor:
Bruce Webber, Barbara F. Williams, John K. French, Martin J. Frey, Stephanie C McLaughlin, A. A. J. Adgey, Harvey D. White, Philip E. Aylward, Ivan T. Straznicky
Publikováno v:
Heart. 81:128-133
Objective To assess whether the 90 minute corrected thrombolysis in myocardial infarction frame count (CTFC) in the infarct related artery predicts left ventricular function at 48 hours in patients with myocardial infarction treated with aspirin, str
Autor:
John K. French, Harvey D. White, Chris Ellis, David J Amos, Ralph M.L. Whitlock, Bruce Webber, Barbara F. Williams, Krishnan Ramanathan
Publikováno v:
The American Journal of Cardiology. 81:665-671
Because 24% to 30% of patent infarct-related arteries occlude in the year following thrombolytic therapy for acute myocardial infarction, angiographic factors including corrected Thrombolysis in Myocardial Infarction (TIMI) frame count which may pred
Autor:
Susan Wyatt, Harvey D. White, Christine Ingram, H.H. Hart, Chris Ellis, John K. French, June E Poole, Barbara F. Williams, M. Williams
Publikováno v:
BMJ. 312:1637-1641
Objective: To determine the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy. Design: Cohort follow up study. Setting: The four coronary care units in Auckland, New Zealand. Subjects: All 30
Autor:
Barbara F. Williams, Harvey D. White, H.H. Hart, David B. Cross, Robin M. Norris, John K. French
Publikováno v:
Heart. 73:500-505
BACKGROUND--The effects of streptokinase on the occurrence of a combined clinical outcome in patients presenting with recent chest pain and ST depression were investigated in view of the role of thrombus in the pathogenesis of acute ischaemic syndrom
Autor:
Barbara F. Williams, Alan R. Kerr, Harvey D. White, K A Abraham, M C Ramage, Andrew Hamer, M Takayama, A H Roche
Publikováno v:
Circulation. 90:2899-2904
BACKGROUND Left ventricular function is the main predictor of long-term survival in patients with coronary artery disease. In patients with impaired left ventricular function after myocardial infarction, end-systolic volume is a better predictor than
Autor:
Barbara F. Williams, David B. Cross, Kam S. Woo, Harvey D. White, H.H. Hart, A. H. Maslowski, M P Caruana, Robin M. Norris
Publikováno v:
Heart. 69:492-495
OBJECTIVE--To investigate the hypothesis that the magnitude of the life saving effect of aspirin in the second international study of infarct survival (ISIS-2) trial cannot be explained solely by prevention of late reocclusion of the infarct related
Publikováno v:
Coronary Artery Disease. 4:201-206
BACKGROUND We investigated whether the proportion of creatine kinase (CK) MM3 to total MM isoform, measured in a single blood specimen taken at 3 hours after starting intravenous administration of streptokinase to patients with developing myocardial